Skip to main content

Table 3 Results of the gene-set enrichment analysis of the Biocarta pathway for disease control

From: Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan

 

Biocarta Pathway

Pathway description

Number of genes

Efron-Tibshirani’s GSA test p-value

1

h_CCR3Pathway

CCR3 signaling in eosinophils

8

0.005 (−)

2

h_cdMacPathway

Cadmium induces DNA synthesis and proliferation in macrophages

6

0.005 (−)

3

h_integrinPathway

Integrin Signaling Pathway

10

0.005 (−)